Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) currently has a daily average trading volume of 3.21M but it saw 2428978 shares traded in last market. With a market cap of 572.98M USD, the company’s current market price of $2.25 came falling about -6.25 while comparing to the previous closing price of $2.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.50 and as low as $1.66.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which downgraded the stock as “Neutral” in its note to investors issued on February 26, 2025, recommending a price target of between $9 and $3 for it. Goldman also issued its recommendations for the stock as it downgraded the price target for the stock is $4.25.
Over the week, MRVI’s stock price is moving 13.64% up while it is 16.58% when we observe its performance for the past one month. Year-to-date it is -58.72% down and over the past year, the stock is showing a downside performance of -80.12%.
Currently, Maravai LifeSciences Holdings Inc’s total number of outstanding shares is 143.96M with 1.97% of that held by the insiders while 90.27% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -26.20% and return on equity (ROE) at -45.75%. Stock’s beta reads 0.24. Stock has a price to book (P/B) ratio of 1.08 while price to sale or P/S ratio amounts to 2.37. Its return on asset (ROA) is -13.53% on average.
